viewUK Oil & Gas PLC

UK Oil & Gas and Alba gallop higher after Horse Hill approval

Regulatory approval removes a significant roadblock from progress on the prospect

UK Oil & Gas PLC -

UK Oil & Gas PLC (LON:UKOG) said the Oil and Gas Authority (OGA) has approved the Horse Hill Field Development Plan.

The OGA has also consented to the start of long-term production from the field, which is located near London's Gatwick Airport.

UK Oil & Gas (UKOG) owns a controlling 85.635% interest in the Horse Hill oil field and the surrounding PEDL 137 and PEDL 246 licences; Alba Mineral Resources PLC (LON:ALBA) has an 11.765% interest in the licences.

The OGA’s decision will enable net recoverable reserves to be allocated to UKOG, which is a pre-requisite for future potential debt-based funding. It will also permit UKOG to enter into long-term field operations contracts that could help reduce operating costs below US$19 per barrel, making the field more profitable even at current low oil prices.

Oil pool production from the Portland formation will commence via Horse Hill-1 (HH-1), with Kimmeridge production planned to be added in late spring via conversion of the well to a dual completion.

Production from HH-2z is planned to follow upon completion of the current extended well testing campaign, UKOG revealed.

"This is an important regulatory milestone, granting governmental production consent. The company can now focus firmly upon maximising stable production, reducing operating costs and generating positive cash flow. The ability to book reserves also opens the way to potential debt funding, a positive step towards both creation and preservation of shareholder value,” said Stephen Sanderson, UKOG’s chief executive.

George Frangeskides, Alba's executive chairman, welcomed the confirmation by the OGA.

Shares in UKOG shot up 27% to 0.47p on the news while Alba climbed 14% to 0.08p.


Quick facts: UK Oil & Gas PLC

Price: 0.13 GBX

Market: AIM
Market Cap: £16.84 m

Add related topics to MyProactive

Create your account: sign up and get ahead on news and events


The Company is a publisher. You understand and agree that no content published on the Site constitutes a recommendation that any particular security, portfolio of securities, transaction, or investment strategy is...


Bionomics' positive pharmacokinetic results confirms it can begin second...

Bionomics Limited (ASX:BNO) (OTCQB:BNOEF) Executive Chairman Errol De Souza tells Proactive tells Proactive the Adelaide, Australia- based biopharmaceutical company has received positive pharmacokinetic results from a 7-day dosing study to treat PTSD, using its new formulation of BNC210. De...

1 day, 9 hours ago

2 min read